7 Results for "

Syringic acid

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Syringic acid" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-N0339
CAS No.: 530-57-4
Syringic acid is correlated with high antioxidant activity and inhibition of LDL oxidation.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N6654
CAS No.: 530-56-3
Synonyms: Syringic Alcohol
Target:  

Drug Derivative

Research Areas:  

Others

Syringyl Alcohol (Syringic Alcohol) is a derivate of phenol comprises both phenolic and alcoholic functional groups. Syringyl Alcohol is a probe molecule for the evaluation of the catalytic performance of various carbonaceous nanomaterials (CNMs) .
loading...
    loading...
Cat. No.: HY-N0339R
CAS No.: 530-57-4
Syringic acid (Standard) is the analytical standard of Syringic acid. This product is intended for research and analytical applications. Syringic acid is correlated with high antioxidant activity and inhibition of LDL oxidation.
loading...
    loading...
Cat. No.: HY-P6299
CAS No.: 944792-75-0
Research Areas:  

Neurological Disease Cancer

MAX8 is a synthetic β-hairpin peptide that folds rapidly and self-assembles into a β-sheet-rich fibrous hydrogel network via non-covalent crosslinking. MAX8 hydrogel exhibits excellent shear-thinning and self-healing properties, enabling precise delivery via syringe and maintaining local retention after implantation. MAX8 hydrogel can uniformly encapsulate cells while preserving their viability and morphology, and protect growth factors (e.g., NGF) and chemotherapeutic drugs from degradation. MAX8 is applicable for spinal cord injury repair, medulloblastoma treatment, and three-dimensional high-throughput drug screening .
loading...
    loading...
Cat. No.: HY-N0339S
CAS No.: 84759-06-8
Syringic acid-d6 is the deuterium labeled Syringic acid . Syringic acid is correlated with high antioxidant activity and inhibition of LDL oxidation .
loading...
    loading...
Cat. No.: HY-16387
CAS No.: 854514-88-8
Target:  

VEGFR

Research Areas:  

Others

PF-00337210 is a potent and selective inhibitor of VEGFRs, designed for treating age-related macular degeneration via intravitreal injection. The formulation strategy focused on developing an ophthalmic solution that would precipitate upon injection into the vitreous, ensuring sustained drug delivery. Challenges included maintaining low dosing volumes, selecting safe excipients for intravitreal use, and addressing the drug's unique physicochemical properties. The final formulation, an isotonic solution in a citrate-buffered vehicle with NaCl, demonstrated stability, potency, and recovery through intravitreal dosing syringes. It formed a depot upon injection into vitreous humor, representing a novel nonpolymeric in situ-forming depot formulation for intravitreal drug delivery .
loading...
    loading...
Cat. No.: HY-P10699
CAS No.: 487036-63-5
Research Areas:  

Neurological Disease Cancer

MAX1 is a synthetic β-hairpin peptide that folds rapidly and self-assembles into a β-sheet-rich fibrous hydrogel network via non-covalent crosslinking. MAX1 hydrogel exhibits excellent shear-thinning and self-healing properties, enabling precise delivery via syringe and maintaining local retention after implantation. MAX1 hydrogel can uniformly encapsulate cells while preserving their viability and morphology, and protect growth factors (e.g., NGF) and chemotherapeutic drugs from degradation. MAX1 is applicable for spinal cord injury repair, medulloblastoma treatment, and three-dimensional high-throughput drug screening .
loading...
    loading...